Related Experiment Video
Updated: Aug 15, 2026
10:10
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
Published on: October 27, 2009
[Effect of aggregation inhibitors on thrombocyte enzymatic activity]
Farmakologiia I Toksikologiia
|May 1, 1978
Summary
Certain drugs inhibit platelet aggregation and alter carbohydrate metabolism in rabbit blood cells. These compounds affect key enzymes involved in energy production and glucose processing.
Area of Science:
- Biochemistry
- Pharmacology
- Hematology
Context:
- Platelet aggregation plays a crucial role in thrombosis.
- Carbohydrate metabolism is vital for cellular energy production.
- Understanding drug effects on thrombocytes is important for cardiovascular research.
Purpose:
- To investigate the effects of specific drugs on thrombocyte function.
- To analyze the impact of these drugs on carbohydrate metabolism enzymes within thrombocytes.
Summary:
- Experiments in rabbits demonstrated that amidopyrin, sulphatizonicotinoilamine-guanidine, chlorpromazine, triphthazine, euphylline, and tedamine inhibit platelet aggregation.
- These drugs also affect carbohydrate metabolism enzymes in thrombocytes, both in vitro and in vivo.
- Specifically, they activate lactate dehydrogenase and glyceraldehyde-3-phosphate dehydrogenase while reducing glucose-6-phosphate dehydrogenase activity.
Impact:
- Provides insights into the pharmacological mechanisms of these drugs on platelet function.
- Highlights potential therapeutic applications in conditions involving platelet aggregation and metabolic disorders.
- Contributes to the understanding of drug-induced alterations in cellular energy metabolism.
Related Concept Videos
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.